Patent Assignment
Reel/Frame 067239/0491
Release of Security Interest
Recorded: 2024-04-25
Pages: 37
Assignor
WILMINGTON TRUST, NATIONAL ASSOCIATION
Executed: 2024-04-23
Assignees
ACTIENT PHARMACEUTICALS LLC
1400 ATWATER DRIVE, MALVERN, PENNSYLVANIA, 19355
ASTORA WOMEN’S HEALTH LLC
1400 ATWATER DRIVE, MALVERN, PENNSYLVANIA, 19355
AUXILIUM PHARMACEUTICALS, LLC
1400 ATWATER DRIVE, MALVERN, PENNSYLVANIA, 19355
AUXILIUM US HOLDINGS, LLC
1400 ATWATER DRIVE, MALVERN, PENNSYLVANIA, 19355
BIOSPECIFICS TECHNOLOGIES CORP.
1400 ATWATER DRIVE, MALVERN, PENNSYLVANIA, 19355
BIOSPECIFICS TECHNOLOGIES LLC
1400 ATWATER DRIVE, MALVERN, PENNSYLVANIA, 19355
DAVA INTERNATIONAL, LLC
1400 ATWATER DRIVE, MALVERN, PENNSYLVANIA, 19355
DAVA PHARMACEUTICALS, LLC
ONE RAM RIDGE ROAD, CHESTNUT RIDGE, NEW YORK, 10977
ENDO PHARMACEUTICALS INC.
1400 ATWATER DRIVE, MALVERN, PENNSYLVANIA, 19355
ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.)
1400 ATWATER DRIVE, MALVERN, PENNSYLVANIA, 19355
GENERICS BIDCO I, LLC
ONE RAM RIDGE ROAD, CHESTNUT RIDGE, NEW YORK, 10977
GENERICS INTERNATIONAL (US), INC.
ONE RAM RIDGE ROAD, CHESTNUT RIDGE, NEW YORK, 10977
PAR PHARMACEUTICAL, INC.
ONE RAM RIDGE ROAD, CHESTNUT RIDGE, NEW YORK, 10977
PAR PHARMACEUTICAL COMPANIES, INC.
ONE RAM RIDGE ROAD, CHESTNUT RIDGE, NEW YORK, 10977
PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC)
6 RAM RIDGE ROAD, CHESTNUT RIDGE, NEW YORK, 10977
QUARTZ SPECIALTY PHARMACEUTICALS, LLC
ONE RAM RIDGE ROAD, CHESTNUT RIDGE, NEW YORK, 10977
SLATE PHARMACEUTICALS, LLC
1400 ATWATER DRIVE, MALVERN, PENNSYLVANIA, 19355
VINTAGE PHARMACEUTICALS, LLC
ONE RAM RIDGE ROAD, CHESTNUT RIDGE, NEW YORK, 10977
Covered Properties
(199)
Endopelvic Fascia Treatment for Incontinence
Patent:
6,292,700 →
Application:
09/413,100 →
Sequential benzylic oxidations of the naloxone ring system
Patent:
6,166,211 →
Application:
09/520,099 →
Intrademal-Penetration Agents for Topical Local Anesthetic Administration
Patent:
6,455,066 →
Application:
09/523,652 →
Devices, Methods, and Systems for Shrinking Tissues
Patent:
6,587,731 →
Application:
09/598,076 →
Method of forming adhesive patch for applying medication to the skin
Patent:
6,361,790 →
Application:
09/629,783 →
Interspersed Heating/Cooling to Shrink Tissues for Incontinence
Patent:
6,572,639 →
Application:
09/636,795 →
Nonivasive Devices and Methods for Shrinking of Tissues
Patent:
6,546,934 →
Application:
09/651,435 →
Processes for preparing flutamide compounds and compounds prepared by such processes
Patent:
6,228,401 →
Application:
09/685,443 →
Particulate Drug-Containing Products and Method of Manufacture
Flocculated Suspension of Megestrol Acetate
Noninvasive Devices, Methods, and Systems for Shrinking of Tissues
Noninvasive Devices, Methods, and Systems for Shrinking of Tissues
Control of Urge Incontinence
Patent:
6,652,449 →
Application:
09/806,970 →
Urinary Incontinence Diagnostic System
Delivery Vehicle Composition and Methods for Delivering Antigens and Other Drugs
Methods for Use of Delivery Composition for Expanding, Activating, Committing or Mobilizing One or More Pluripotent, Self-Renewing and Committed Stem Cells
Sling Delivery System and Method of Use
Surgical Instrument and Method
Implantable Article and Method for Treating Urinary Incontinence Using Means for Repositioning the Implantable Article.
Ribbed Electrodes and Methods for Their Use
Patent:
6,533,780 →
Application:
09/925,501 →
Implantable Article and Method
Sling Adjustment and Tensioning Accessory
Patent:
6,702,827 →
Application:
09/968,239 →
Sling Assembly with Secure and Convenient Attachment
Incontinence Treatment with Urethral Guide
Pelvic Disorder Treatment
Systems and Methods Using Vasoconstriction for Improved Thermal Treatment of Tissues
Incontinence Treatment Device
Low Power Consumption Implantable Pressure Sensor
Heating Method for Tissue Contraction
Flocculated Suspension of Megestrol Acetate
Sustained Release Formulations of Oxymorphone
Oxymorphone controlled release formulations
Intradermal-Penetration Agents for Topical Local Anesthetic Administration
Needle Deployment for Temperature Sensing from an Electrode
Surgical Instruments for Addressing Pelvic Disorders
Sling Delivery System and Method of Use
Surgical Articles and Methods
Transobturator Surgical Articles and Methods
Pelvic Floor Implant System and Method of Assembly
Ribbed Electrodes and Methods for Their Use
Transobturator Surgical Articles and Methods
Implanting Device and Method of Using Same
Method and Apparatus for Correction of Urinary and Gynecological Pathologies, Including Treatment of Incontinence Cystocele
Implantable Article and Method
Devices, Methods, and Systems for Shrinking Tissues
Pelvic Disorder Treatment Device
Implantable Article for Treatment of Urinary Incontinence
Surgical Instrument and Method
Sling Assembly with Secure and Convenient Attachment
Methods and Apparatus for Correction of Urinary and Gynecological Pathologies, Including Treatment of Male Incontinence, and Female Cystocele
Sustained Release Formulations of Metformin
Surgical Article and Methods for Treating Female Urinary Incontinence
Control of Urge Incontinence
Surgical Articles and Methods
Particulate Drug-Containing Products and Method of Manufacture
Handle and Surgical Article
Non-Surgical Incontinence Treatment System and Method
Electrically Heated/Phase Change Probe Temperature Control
Heating Method for Tissue Contraction
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Patent:
7,229,636 →
Application:
10/787,385 →
Incontinence Treatment with Urethral Guide
Prolapse Repair
Nasal Calcitonin Formulations Containing Chlorobutanol
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Patent:
7,404,489 →
Application:
10/814,399 →
Energy Induced Bulking and Buttressing of Tissue for Incontinence
Energy Induced Bulking and Buttressing of Tissues for Incontinence
Method and Apparatus for Treating Pelvic Organ Prolapse
Method and Apparatus for Cystocele Repair
Devices, Methods, and Systems for Shrinking Tissues
Implantable Article and Method
Delayed Release Dosage Forms
Incontinence Treatment Device
Endo-Pelvic Fascia Penetrating Heating Systems and Methods for Incontinence Treatment
Transobturator Surgical Articles and Methods
Heating Method for Tissue Contraction
Surgical Implants and Related Methods
Compositions and Methods for Treating Precocious Puberty
Implantable Article for the Treatment of Incontinence
Surgical articles and methods
Sling Delivery System and Method of Use
Method for Supporting Vaginal Cuff
Transobturator Surgical Articles and Methods
Controlled Release Formulations of Octreotide
Surgical Instruments
Apparatus for Treating Stress and Urge Incontinence
Oxymorphone Controlled Release Formulations
Application:
11/425,966 →
Publication:
US 2007/0098792
Oxymorphone Controlled Release Formulations
Sustained release formulations of nalbuphine
Method of Inserting an Object Under the Skin
Sling Assembly with Secure and Convenient Attachment
Oxymorphone Controlled Release Formulations
Sustained Release Matrix Systems for Highly Soluble Drugs
Pelvic Floor Implant System and Method of Assembly
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Application:
11/766,740 →
Publication:
US 2008/0318994
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
Application:
11/766,748 →
Publication:
US 2009/0124650
Systems, Apparatus and Associated Methods for Needleless Delivery of Therapeutic Fluids
Pelvic health implants and methods
Implantable Article and Method
Pelvic health implants and methods
Methods and Systems for Treatment of Prolapse
Prolapse Repair
Method and Apparatus for Cystocele Repair
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Multi-Leveled Transgluteal Tension-Free Levatorplasty for Treatment of Rectocele
Incontinence Treatment Device
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Sustained Release Formulations of Nalbuphine
Oxymorphone Controlled Release Formulations
Application:
12/167,859 →
Publication:
US 2008/0262013
Delivery of Dry Formulations of Octreotide
Controlled Release Formulations of Octreotide
Electrode Sling for Treating Stress and Urge Incontinence
Method and Apparatus for Treating Pelvic Organ Prolapse
Methods and Apparatus for Correction of Urinary and Gynecological Pathologies, Including Treatment of Male Incontinence, and Female Cystocele
Combination Treatment for Bladder Cancer
Implantation Device for Subcutaneous Implatation of an Object Under the Skin
Method and Apparatus for Prolapse Repair
Pelvic Disorder Treatment
An Implantable Device for the Sustained Release of a Polypeptide
Octreotide Implant Having a Release Agent and Uses Thereof
Kit For Levator Avulsion Repair
Vitamin B12 Nasal Spray and Method of Use
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Controlled Release Formulations of Octreotide
A Method of Manufacturing an Implantable Device
Nasal Calcitonin Formulations Containing Chlorobutanol
Sling Delivery System and Method of Use
Method for Supporting Vaginal Cuff
Octreotide Implant Having a Release Agent
Sling Assembly with Secure and Convenient Attachment
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Prolapse Repair
Transobturator Surgical Articles and Methods
Implantable Article and Method
Nasal Calcitonin Formulations Containing Chlorobutanol
Methods and Apparatus for Correction of Urinary and Gynecological Pathologies, Including Treatment of Male Incontinence, and Female Cystocele
Apparatus and Method for Repairing Vaginal Reconstruction
Sustained Release Formulation of Nalbuphine
Implantable Article and Method
Method of Manufacturing an Implantable Device
Sling Delivery System and Method of Use
Systems, Apparatus and Associated Methods for Needleless Delivery of Therapeutic Fluids
Methods and Systems for Treatment of Prolapse
Crystalline, Anhydrous Forms of Oxymorphone Hydrochloride
Method for Supporting Vaginal Cuff
Implantable Article and Method
Pelvic Health Implants and Methods
Sustained Release Formulation of Nalbuphine
Prolapse Repair
Sustained Release Formulation of Nalbuphine
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Surgical Articles and Methods
Transobturator Surgical Articles and Methods
Implantable Article and Method
Crystalline, Anhydrous Forms of Oxymorphone Hydrochloride
Epinephrine Formulations
Patent:
9,119,876 →
Application:
14/657,990 →
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Patent:
9,375,478 →
Application:
14/717,882 →
Vitamin B12 Nasal Spray and Method of Use
Methods and Systems for Treatment of Prolapse
Epinephrine Formulations
Patent:
9,295,657 →
Application:
14/818,121 →
Epinephrine Formulations
Vitamin B12 Nasal Spray and Method of Use
Implantable Article and Method
Systems and Methods for Treating a Pelvic Disorder
Sustained Release Formulation of Nalbuphine
Application:
15/162,062 →
Publication:
US 2016/0263035
Delivery of Dry Formulations of Octreotide
Application:
15/246,009 →
Publication:
US 2017/0049850
Controlled Release Formulations of Octreotide
Application:
15/246,020 →
Publication:
US 2017/0100461
Crystalline, Anhydrous Forms of Oxymorphone Hydrochloride
Vasopressin Formulations for Use in Treatment of Hypotension
Surgical Articles and Methods
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Sustained Release Formulation of Nalbuphine
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Epinephrine Formulations
Application:
15/969,500 →
Publication:
US 2018/0250245
Compositions and Methods for Treating Precocious Puberty
Application:
16/002,578 →
Publication:
US 2018/0280467
Oxymorphone Controlled Release Compositions
Application:
16/049,390 →
Publication:
US 2018/0338967
Peptide Congeners with Polymer Excipients
Application:
16/161,277 →
Publication:
US 2020/0188474
Systems and Methods for Treating a Pelvic Disorder
Epinephrine Formulations
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Application:
16/359,659 →
Publication:
US 2019/0201476
Implantable Device for the Delivery of Octreotide and Methods of Use Thereof
Application:
16/456,601 →
Publication:
US 2019/0365847
Controlled Release Formulations of Octreotide
Application:
16/548,682 →
Publication:
US 2020/0046806
Epinephrine Formulations
Implanting Device
Patent:
492,995 →
Application:
29/179,382 →
Handle for a Surgical Instrument
Patent:
543,626 →
Application:
29/195,937 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →
Release of Patent Security Interest
Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 032380/0198 →
Release of Patent Security Interest in Exclusively Licensed Patents
Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS SOLUTIONS INC.
Reel/Frame 032380/0157 →
Release of Patent Security Interest
Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
Grant of Security Interest in Licensed Patents
Mar 20, 2014
From: ENDO PHARMACEUTICALS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0620 →
Grant of Security Interest in Patents
Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
Corrective Assignment to Correct the Name of Receiving Party in Release of Patent Security Interest in Exclusively Licensed Patents Previously Recorded on Reel 032380 Frame 0157. Assignor(S) Hereby Confirms the Release of Security Interest in Exclusively Licensed Patents..
Mar 24, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 032513/0255 →
Assignment of Assignor's Interest
Mar 23, 2015
From: KANNAN, VINAYAGAM; IRISH, PATRICK; BERGREN, MICHAEL
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 035230/0772 →
Assignment of Assignor's Interest
Jul 9, 2015
From: IMMUNE PHARMACEUTICALS INC. (SUCCESSOR IN INTEREST OF EPICEPT)
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 036043/0355 →
Release of Security Interest
Aug 5, 2015
From: MIDCAP FINANCIAL TRUST
To: IMMUNE PHARMACEUTICALS, INC.; MAXIM PHARMACEUTICALS, INC.; CYTOVIA, INC.
Reel/Frame 036278/0673 →
Release of Security Interest
Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded at Reel: 017125 Frame: 291. Assignor(S) Hereby Confirms the Assignment.
Sep 1, 2015
From: TEVA PHARMACEUTICALS USA, INC.
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 036515/0652 →
Confirmatory Grant of Security Interest in United States Patents
Sep 25, 2015
From: PAR PHARMACEUTICAL, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 036687/0821 →
Confirmatory Grant of Security Interest in United States Patents
Sep 25, 2015
From: PAR PHARMACEUTICAL COMPANIES, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 036687/0899 →
Release of Security Interest
Sep 30, 2015
From: BANK OF AMERICA, N.A.
To: PAR PHARMACEUTICAL, INC.; INNOTEQ, INC.; PAR PHARMACEUTICAL COMPANIES, INC.
Reel/Frame 036695/0782 →
Change of Name
Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0607 →
Change of Name
Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0318 →
Change of Name
Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0354 →
Assignment of Assignor's Interest
Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0260 →
Assignment of Assignor's Interest
Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0425 →
Change of Name
Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0535 →
Corrective Assignment to Correct the Conveying Party Name Previously Recorded at Reel: 037300 Frame: 0607. Assignor(S) Hereby Confirms the Assignment.
Jan 11, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037514/0402 →
Change of Address
Apr 1, 2016
From: PAR PHARMACEUTICAL, INC.
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 038324/0885 →
Corrective Assignment to Correct the Assignor Name Previously Recorded at Reel: 037300 Frame: 0318. Assignor(S) Hereby Confirms the Change of Name.
Sep 6, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 039919/0017 →
Release of Security Interest
Apr 28, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: PAR PHARMACEUTICAL, INC.; ENDO GENERICS HOLDINGS, INC.; INNOTEQ, INC.
Reel/Frame 042171/0036 →